| 4 | Bacterial and fungal co-infection is a major barrier in COVID-19 patients:A specific management and therapeutic strategy is required显示文摘Microbial co-infections are another primary concern in patients with coronavirus disease 2019(COVID-19),yet it is an untouched area among researchers.Preliminary data and systematic reviews only show the type of pathogens responsible for that,but its pathophysiology is still unknown.Studies show that these microbial co-infections are hospital-acquired/nosocomial infections,and patients admitted to intensive care units with invasive mechanical ventilation are highly susceptible to it.Patients with COVID-19 had elevated inflammatory cytokines and a weakened cell-mediated immune response,with lower CD4+T and CD8+T cell counts,indicating vulnerability to various co-infections.Despite this,there are only a few studies that recommend the management of coinfections. | Tarun Sahu Henu Kumar Verma Lakkakula V K S Bhaskar | 2022 | World Journal of Virology2022，11，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员